Skip to main content
. 2012 Nov 15;8(2):241–247. doi: 10.2215/CJN.03760412

Figure 2.

Figure 2.

Estimated probability of achieving a given age free of doubling of serum creatinine or graft loss (DSCGL). Results are reported according to three baseline serum creatinine concentrations for an otherwise “average” participant in the Assessment of Lescol in Renal Transplant (ALERT) trial.